Literature DB >> 2562809

In vitro phosphorylation of bovine adrenal chromaffin cell tyrosine hydroxylase by endogenous protein kinases.

R J George1, J W Haycock, J P Johnston, G L Craviso, J C Waymire.   

Abstract

Under phosphorylating conditions, addition of Ca2+ or cyclic AMP to the 100,000 g supernatant of purified bovine adrenal chromaffin cells increases both the incorporation of 32P into tyrosine hydroxylase and the activity of the enzyme. Combining maximally effective concentrations of each of these stimulating agents produces an additive increase in both the level of 32P incorporation into tyrosine hydroxylase and the degree of activation of the enzyme. The increased phosphorylation by Ca2+ is due to stimulation of endogenous Ca2+-dependent protein kinase activity and not inhibition of phosphoprotein phosphatases. When the chromaffin cell supernatant is subjected to diethylaminoethyl (DEAE) chromatography to remove calmodulin and phospholipids, tyrosine hydroxylase is no longer phosphorylated or activated by Ca2+; on the other hand, phosphorylation and activation of tyrosine hydroxylase by cyclic AMP are not affected. Subsequent replacement of either Ca2+ plus calmodulin or Ca2+ plus phosphatidylserine to the DEAE-fractionated cell supernatant restores the phosphorylation, but not activation of the enzyme. Reverse-phase HPLC peptide mapping of tryptic digests of tyrosine hydroxylase from the 100,000 g supernatant shows that the Ca2+-dependent phosphorylation occurs on three phosphopeptides, whereas the cyclic AMP-dependent phosphorylation occurs on one of these peptides. In the DEAE preparation, either cyclic AMP alone or Ca2+ in the presence of phosphatidylserine stimulates the phosphorylation of only a single phosphopeptide peak, the same peptide phosphorylated by cyclic AMP in the crude supernatant. In contrast, Ca2+ in the presence of calmodulin stimulates the phosphorylation of three peptides having reverse-phase HPLC retention times that are identical to peptides phosphorylated by Ca2+ addition to the crude unfractionated 100,000 g supernatant. Rechromatography of the peaks from each of the in vitro phosphorylations, either in combination with each other or in combination with each of the seven peaks generated from phosphorylation of tyrosine hydroxylase in situ, established that cyclic AMP, Ca2+/phosphatidylserine, and Ca2+/calmodulin all stimulate the phosphorylation of the same reverse-phase HPLC peptide: in situ peptide 6. Ca2+/calmodulin stimulates the phosphorylation of in situ peptides 3 and 5 as well. Thus, tyrosine hydroxylase can be phosphorylated in vitro by protein kinases endogenous to the chromaffin cell. Phosphorylation occurs on a maximum of three of the seven in situ phosphorylated sites, and all three of these sites can be phosphorylated by a Ca2+/calmodulin-dependent protein kinase.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2562809     DOI: 10.1111/j.1471-4159.1989.tb10928.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  10 in total

1.  Is prolactin playing a role in the regulation of catecholamine synthesis and release from male rat adrenal medulla?

Authors:  M L Hernández; R de Miguel; J A Ramos; J J Fernández-Ruiz
Journal:  J Endocrinol Invest       Date:  1991-03       Impact factor: 4.256

2.  Myeloid adrenergic signaling via CaMKII forms a feedforward loop of catecholamine biosynthesis.

Authors:  Yan Luo; Bilian Liu; Xin Yang; Xiaoxiao Ma; Xing Zhang; Denis E Bragin; Xuexian O Yang; Wendong Huang; Meilian Liu
Journal:  J Mol Cell Biol       Date:  2017-10-01       Impact factor: 6.216

Review 3.  Calcium/calmodulin-dependent protein kinase II.

Authors:  R J Colbran; C M Schworer; Y Hashimoto; Y L Fong; D P Rich; M K Smith; T R Soderling
Journal:  Biochem J       Date:  1989-03-01       Impact factor: 3.857

4.  Inhibition of nicotinic responses of bovine adrenal chromaffin cells by the protein kinase C inhibitor, Ro 31-8220.

Authors:  P D Marley; K A Thomson
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

Review 5.  A synopsis on the role of tyrosine hydroxylase in Parkinson's disease.

Authors:  Shams Tabrez; Nasimudeen R Jabir; Shazi Shakil; Nigel H Greig; Qamre Alam; Adel M Abuzenadah; Ghazi A Damanhouri; Mohammad A Kamal
Journal:  CNS Neurol Disord Drug Targets       Date:  2012-06-01       Impact factor: 4.388

6.  Protein kinase A and nicotinic activation of bovine adrenal tyrosine hydroxylase.

Authors:  P D Marley; K A Thomson; R A Bralow
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

7.  Cholinoceptor regulation of cyclic AMP levels in bovine adrenal medullary cells.

Authors:  K Anderson; P J Robinson; P D Marley
Journal:  Br J Pharmacol       Date:  1992-06       Impact factor: 8.739

8.  Multiple signaling pathways in bovine chromaffin cells regulate tyrosine hydroxylase phosphorylation at Ser19, Ser31, and Ser40.

Authors:  J W Haycock
Journal:  Neurochem Res       Date:  1993-01       Impact factor: 3.996

9.  Identification by hydrogen/deuterium exchange of structural changes in tyrosine hydroxylase associated with regulation.

Authors:  Shanzhi Wang; Giri R Sura; Lawrence J Dangott; Paul F Fitzpatrick
Journal:  Biochemistry       Date:  2009-06-09       Impact factor: 3.162

10.  Alpha-synuclein aggregation alters tyrosine hydroxylase phosphorylation and immunoreactivity: lessons from viral transduction of knockout mice.

Authors:  Tshianda N M Alerte; Akinwande A Akinfolarin; Emily E Friedrich; Samantha A Mader; Chang-Sook Hong; Ruth G Perez
Journal:  Neurosci Lett       Date:  2008-02-12       Impact factor: 3.046

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.